Tarsus Pharmaceuticals, Inc.

TARS

—

Advanced chart & tools →

Tarsus Pharmaceuticals, Inc.TARS

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.59

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$451.36M

Net income

$-66.42M

Net margin

-14.7%

Gross margin

—

Dividends & financials

Tarsus Pharmaceuticals, Inc. (TARS) reported revenue of $451.36M and net income of $-66.42M, or $-1.59 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.